首页> 中文期刊> 《基层医学论坛》 >医用透明质酸钠预防甲状腺术后粘连90例

医用透明质酸钠预防甲状腺术后粘连90例

         

摘要

ObjectiveThe aim of the present study is to investigate the clinical utility of sodium hyaluronate in prevention of postoperative adhesions of thyroid.MethodsDecide the thyroid surgery of 2365 cases from 2006-2014 in our hospital. 96 cases were not medical sodium hyaluronate medication,as control group. 90 cases of medical sodium hyaluronatedrug treatment(wound smearing)as the observation group.Patients were followed up for 4 months,compared the proportion of adhesion morbidity of two groups patient.ResultsIn observation group the postoperative adhesion symptoms occurred in 17 cases,accounting for 18.9% of all patients. in control group the adhesion symptoms occurred in 40 cases,accounted for 41.7% of all patients.Compared with the control group,sodium hyaluronate treatment significantly reduced the incidence of thyroid postoperative adhesions(P<0.01).ConclusionOur study preliminary explored the preventive effect of sodium hyaluronate in reduce the incidence of postoperative adhesion of thyroid operation.%目的:探讨医用透明质酸钠预防甲状腺术后粘连的临床效果。方法2006年1月—2014年1月186例甲状腺手术患者,96例未进行医用透明质酸钠用药作为对照组,90例进行医用透明质酸钠用药处理(创面涂抹)作为观察组。术后随访4个月,对2组患者的术后粘连情况进行比较。结果术后4个月内2组患者均未发生切口感染和过敏反应。其中,观察组中发生术后粘连17例,占18.9%;对照组中发生术后粘连40例,占41.7%,2组比较有显著差异(P<0.01)。结论甲状腺术后粘连发病率较高,透明质酸钠能有效降低其发生率,值得临床推广。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号